Get the Stockscreener App
95.10
0.16%
0.15
Mesa Laboratories Inc stock is traded at $95.10, with a volume of 174.25K.
It is up +0.16% in the last 24 hours and down -6.09% over the past month.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
See More
Previous Close:
$94.95
Open:
$95.68
24h Volume:
174.25K
Relative Volume:
1.10
Market Cap:
$525.42M
Revenue:
$249.13M
Net Income/Loss:
$6.71M
P/E Ratio:
78.75
EPS:
1.2076
Net Cash Flow:
$39.58M
1W Performance:
-11.41%
1M Performance:
-6.09%
6M Performance:
+17.99%
1Y Performance:
+2.27%
1-Day Range:
$94.14
$97.80
1-Week Range:
$93.62
$110.14
52-Week Range:
$55.45
$113.99
Mesa Laboratories Inc Stock (MLAB) Company Profile
Name
Mesa Laboratories Inc
Sector
Phone
(303) 987-8000
Address
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs COHR, KEYS, GRMN, TDY, MKSI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
95.10 | 525.42M | 249.13M | 6.71M | 39.58M | 1.2076 |
COHR
Coherent Corp
|
389.57 | 76.22B | 6.60B | 452.58M | -538.24M | 2.0946 |
KEYS
Keysight Technologies Inc
|
363.67 | 62.15B | 6.09B | 1.07B | 1.36B | 6.0693 |
GRMN
Garmin Ltd
|
234.20 | 45.17B | 7.46B | 1.74B | 1.45B | 8.9685 |
TDY
Teledyne Technologies Inc
|
619.58 | 28.70B | 6.22B | 933.70M | 1.05B | 19.76 |
MKSI
Mks Inc
|
406.37 | 27.45B | 4.07B | 328.00M | 380.00M | 4.7842 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-02-20 | Initiated | JP Morgan | Neutral |
| Dec-04-19 | Initiated | Jefferies | Buy |
| Aug-26-19 | Initiated | Evercore ISI | Outperform |
| Jun-10-16 | Downgrade | Sidoti | Buy → Neutral |
View All
Mesa Laboratories Inc Stock (MLAB) Latest News
MLAB SEC FilingsMesa Laboratories 10-K, 10-Q, 8-K Forms - Stock Titan
Mesa Laboratories Inc (MLAB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mesa Laboratories Inc (MLAB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Mesa Laboratories Inc (MLAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mesa Laboratories (MLAB) Falls Nearly 5% as Selling Pressure Tests Key SupportLate Stage Breakouts - newsline.com
Insider Sell: Brian Archbold Sells Shares of Mesa Laboratories I - GuruFocus
Mesa Laboratories CAO Lyndsey Crennen sells $11,949 in shares By Investing.com - Investing.com South Africa
Mesa Laboratories Inc (MLAB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mesa Laboratories CAO Lyndsey Crennen sells $11,949 in shares - Investing.com UK
Mesa Laboratories Inc (MLAB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mesa Laboratories SVP Brian Archbold sells $116,558 in shares By Investing.com - Investing.com Australia
Mesa Labs CFO John Sakys sells $123,849 of company stock - Investing.com UK
Mesa Laboratories (MLAB) CFO sells 1,223 shares to cover RSU tax obligations - Stock Titan
Mesa Laboratories Inc (MLAB) Shares Fall 4.2% -- What GF Score o - GuruFocus
[144] MESA LABORATORIES INC /CO/ SEC Filing - Stock Titan
Mesa Laboratories (NASDAQ: MLAB) SVP exercises options and receives 4,328 RSUs - Stock Titan
Mesa Laboratories (MLAB) CFO exercises awards and receives 8,416 RSUs - Stock Titan
Mesa Laboratories Inc (MLAB) Institutional Confidence - TradingKey
Mesa Laboratories appoints Lyndsey Crennen as chief accounting officer - Investing.com
Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer - TipRanks
Mesa Laboratories appoints Lyndsey Crennen as chief accounting officer By Investing.com - Investing.com UK
Lyndsey Crennen named Chief Accounting Officer at Mesa - TradingView
Mesa Laboratories, Inc. Announces Appointment of Lyndsey Crennen as Chief Accounting Officer - marketscreener.com
Mesa Laboratories (MLAB) appoints Lyndsey Crennen Chief Accounting Officer - Stock Titan
Mesa Laboratories (MLAB) Weakens Amid Sector Headwinds, Testing Key Support LevelsShort Setup Alerts - newsline.com
MLAB Q1 2026 Earnings: EPS Misses Estimates by Significant Margin, Stock DeclinesRevenue Breakdown Analysis - newsline.com
Mesa Laboratories (MLAB) Sees Modest Gains Amid Consolidation Above Key SupportWedge Breakout - newsline.com
MLAB Q1 2026 Earnings: Significant EPS Miss Amid Negative SurpriseFinancial Data - newsline.com
MLAB Q1 2026 Earnings: Significant EPS Miss Despite Surprise Stock GainProfitability Analysis - newsline.com
Mesa Laboratories Stock Slides 4.8%: Key Support Level in FocusHull Moving Average - newsline.com
3 Stocks Estimated To Be Trading 16.4% To 42% Below Intrinsic Value - simplywall.st
MLAB Q1 2026 Earnings: Significant EPS Miss Amidst Operational ChallengesEarnings Whisper Number - newsline.com
Mesa Laboratories Inc. (MLAB) Declines 4.19% as Shares Test Key Support LevelsSector ETF Flow - newsline.com
Mesa Laboratories : Annual Report for Fiscal Year Ending 03-31, 2026 (Form 10-K) - marketscreener.com
Mesa Laboratories, Inc. 2026 Annual Report: Business Overview, Strategy, Segments, and Key Risk Factors - Minichart
Tranche Update on Mesa Laboratories, Inc.'s Equity Buyback Plan announced on November 10, 2005. - marketscreener.com
Mesa Laboratories (NASDAQ: MLAB) outlines global segments, GKE deal and key risks - Stock Titan
MLAB Q1 2026 Earnings: EPS Soars Past Estimates by 695%, Revenue Data UnavailableProfit Guidance Range - The Legal Advocate
Mesa Laboratories (MLAB) Slips 1.05% as Stock Nears Support ZoneStock Buy Zone - The Legal Advocate
Jefferies raises Mesa Laboratories stock price target on CEO outlook By Investing.com - Investing.com Nigeria
Jefferies raises Mesa Laboratories stock price target on CEO outlook - Investing.com
Mesa Labs 4Q Rev $63.7M >MLAB - Moomoo
Mesa Labs 4Q Loss $4.14M >MLAB - Moomoo
Mesa Labs earnings beat by $1.76, revenue fell short of estimates - Investing.com Canada
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today - The Motley Fool
Mesa Laboratories' Stock Slips as 4Q Growth Misses Targets - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Mesa Labs 4Q Loss/Shr 75c >MLAB - Moomoo
Is Mesa Laboratories (MLAB) Modestly Undervalued Despite Q4 FY26 - GuruFocus
Mesa Laboratories Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Mesa Laboratories Inc Stock (MLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):